JUL 19, 2016 09:25 AM PDT

New cures for the common cold?

WRITTEN BY: Kerry Evans
4 8 774
The common cold virus grows best at cooler temperatures (like in your nose), just a few degrees below core body temperature. Why? Because various components of the immune system work better at warm temperatures. Recently, Yale researchers identified two new temperature-dependent host defense strategies that combat the common cold.

The same group already showed that interferon is secreted at 37oC (98.6oF, core body temperature) in response to the cold virus - rhinovirus (RV). However, when they inhibited the interferon response, viral replication still depended partially on temperature, suggesting that additional temperature-dependent antiviral activities were at play.
 
Researchers identified new host defenses against the common cold.
Ultimately, they showed that, at 37oC compared to 33oC, RV-infected cells underwent apoptosis earlier at 37oC than at the cooler temperature of 33oC; virus replication also decreased at 37oC compared to 33oC. In addition, they showed that the RNA-degrading enzyme RNAseL effectively decreased RV replication at 37oC versus 33oC.

To show that apoptosis helped curb viral replication at 37oC, they overexpressed the anti-apoptotic protein Bcl-2. RV replication increased in cells when Bcl-2 was overexpressed (to inhibit apoptosis).

Since dsRNAs accumulate during RV infection, they reasoned that the RNA-degrading enzyme RNAseL may be expressed at a higher level at 37oC than 33oC. This was indeed the case. The level of RNAseL mRNA was 2.2-fold higher at 37oC than 33oC. They used siRNA to knockdown RNAseL production in RV-infected cells; RNAseL knockdown increased RV replication at 37oC compared to when RNaseL was not overexpressed at this temperature..

What’s more, the group found that apoptosis and RNaseL are redundant mechanisms that cells use to control virus replication. To show this, they compared the effects of inhibiting apoptosis and RNAseL simultaneously or separately. In infected control cells, there was a 42-fold difference in peak viral titer at 33oC versus 37oC (indicating enhanced viral replication at 33oC). The difference was 61-fold or 13-fold if RNAseL or apoptosis were inhibited, respectively. However, if both RNAaseL and apoptosis were inhibited simultaneously, there was only a 5-fold difference in peak viral titer.

Overall, these findings reveal new ways to target the common cold, and this is especially important for people who have a weakened immune system or asthma, since the virus can exacerbate symptoms.

Sources: PNAS, Yale, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
MAY 14, 2018
Immunology
MAY 14, 2018
The Immune System's Antibodies Target Multiple Microbes
For the first time, scientists found that antibodies produced by the immune system can target multiple microbes, as opposed to just one type of microbe. Fr
JUL 04, 2018
Drug Discovery
JUL 04, 2018
Increased Dose of Drug 'Rifampin' Effective in Eliminating Tuberculosis Bacterium
According to a randomized controlled trial, a TB drug by the name ‘Rifampin’ was seen to effectively kill TB bacteria in sputum cultures when a
JUL 26, 2018
Microbiology
JUL 26, 2018
How Microbes Communicate Over Long Distances
Percolation isn't only for coffee.
AUG 02, 2018
Immunology
AUG 02, 2018
Chronic Infections Outsmart the Immune System
Chronic parasitic infection shown to take advantage of a mechanism to sustain infection and induce death of white blood cells essential to immune response.
AUG 10, 2018
Videos
AUG 10, 2018
Can the Black Death Make a Comeback?
The bacterium that causes plague was never wiped out.
AUG 11, 2018
Microbiology
AUG 11, 2018
A Microbrewery can Help us Monitor Radiation Exposure
This wearable technology is very sensitive, and can be used by workers that are at risk of radiation exposure.
Loading Comments...